Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 712737 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
ElectronicAdd to Basket
Live Chat Live Help Software for Website

2005 News in Review: Important Changes for the Pharmaceutical

Decision Resources, Inc., Dec 2005, Pages: 12


  Description  
   Table of Contents   
   Companies Mentioned   
    
    
     
  Enquire before Buying   
  Send to a Friend   

This report casts a look back at 2005 and reviews key events and issues in the news that have had a major impact on the pharmaceutical industry or will help shape the industry in the years to come. The report covers ten important news stories:

- The Vioxx withdrawal.
- The Tysabri withdrawal.
- The approval of BiDil for African-Americans.
- Medicare Part D.
- The drug reimportation debate.
- Controversy about political involvement in the drug approval process.
- Concerns about a flu pandemic.
- EU Pharmaceutical Review.
- Reference pricing for statins in Germany.
- Increased consolidation in Japan.




Customers who bought this item also bought

Prescription Drugs - Global Strategic Business Report

Lipid Regulators - Global Strategic Business Report

Top 50 Pharmaceutical Companies & Their Pipelines 2011

Special Report: Successes and Lessons Learned in the Pharmaceutical Industry, 2009

Anti-Hypertensive Drugs - Global Strategic Business Report

Dyslipidemia Therapeutics - Global Strategic Business Report

Big Pharma’s New Licensing Strategies

Human Vaccines - Global Strategic Business Report

Opportunities for Monoclonal Antibodies: Where Companies Are Spending Their Antibody Dollars

Dyslipidemia: Opportunities in Cardiovascular Risk Reduction



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds